RKLB

Rocket Lab USA, Inc.

56
Fundamentals66/ 100
Valuation50/ 100
Upside potential66/ 100
Risk potential46/ 100

RKLB's outlook is improving, though it still trails on the overall score.

SPXC

SPX Technologies, Inc.

69
Fundamentals71/ 100
Valuation71/ 100
Upside potential81/ 100
Risk potential12/ 100

SPXC has the edge over RKLB overall, supported by lower modeled downside and stronger valuation.

RKLB Fundamentals

MetricStatus
Strong
Under pressure
Weak
Unavailable

RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.

SPXC Fundamentals

MetricStatus
Healthy
Healthy
Stable
Stable

SPXC's revenue and profitability are currently healthy, and its cash flow and balance sheet are stable.

RKLB PE Valuation

RKLB has no meaningful PE right now: it lost money over the past year.

SPXC PE Valuation

CHEAPFAIREXPENSIVE44x88x132x177x
CHEAPFAIREXPENSIVE44x88x132x177x
LevelPEPriceVs current
Forward16x$151—
Cheap18x$109-28%
Current25x$151—
Fair35x$208+38%
Expensive70x$412+174%

Historical ranges are pointers, not guarantees.

SPXC's PE is in its fair range at 25x. If earnings grow as analysts expect, today's price would be 16x next year's earnings, in its cheap range.

RKLB Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Limited
Low

RKLB has the edge over SPXC on the outlook, with more favorable profitability expectations.

SPXC Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Stable
Limited
Moderate

Analysts expect strong earnings and revenue growth for SPXC, with profitability holding steady.

RKLB Risk to reward

ScenarioChangePrice
Upside+88%$120.71
Downside-46%$34.64

Calculated from the latest close: $64.07 on Nov 12.

RKLB trails SPXC on modeled risk to reward, with less potential upside relative to its potential downside.

SPXC Risk to reward

ScenarioChangePrice
Upside+50%$226.33
Downside-12%$133.17

Calculated from the latest close: $150.60 on Nov 12.

SPXC has a better modeled risk to reward balance than RKLB, with more potential upside relative to its potential downside.

RKLB Earnings Per Share

Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
QuarterTTM EPSYoY
Q3 2026-$0.36+$0.03
Q2 2026-$0.27+$0.19
Q1 2026-$0.32+$0.09
Q4 2025-$0.37+$0.01
Q3 2025-$0.39-$0.02
Q2 2025-$0.46-$0.11
Q1 2025-$0.41-$0.04
Q4 2024-$0.38$0.00

RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.

SPXC Earnings Per Share

Q4 2023: $1.93Q1 2024: $2.06Q2 2024: $2.23Q3 2024: $3.73Q4 2024: $4.26Q1 2025: $4.30Q2 2025: $4.46Q3 2025: $4.68Q4 2025: $5.03Q1 2026: $5.13Q2 2026: $5.58Q3 2026: $5.92Forward: $9.34
Q4 2023: $1.93Q1 2024: $2.06Q2 2024: $2.23Q3 2024: $3.73Q4 2024: $4.26Q1 2025: $4.30Q2 2025: $4.46Q3 2025: $4.68Q4 2025: $5.03Q1 2026: $5.13Q2 2026: $5.58Q3 2026: $5.92Forward: $9.34
QuarterTTM EPSYoY
Forward$9.34+58%
Q3 2026$5.92+26%
Q2 2026$5.58+25%
Q1 2026$5.13+19%
Q4 2025$5.03+18%
Q3 2025$4.68+25%
Q2 2025$4.46+100%
Q1 2025$4.30+109%
Q4 2024$4.26+121%

SPXC has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.

RKLB Quarterly Revenue

Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
QuarterRevenueYoY
Q3 2026$267.8M+73%
Q2 2026$234.1M+62%
Q1 2026$200.3M+63%
Q4 2025$179.7M+36%
Q3 2025$155.1M+48%
Q2 2025$144.5M+36%
Q1 2025$122.6M+32%
Q4 2024$132.4M+121%

RKLB has the edge over SPXC on sales, with stronger typical year-over-year growth.

SPXC Quarterly Revenue

Q4 2023: $469MQ1 2024: $465MQ2 2024: $501MQ3 2024: $484MQ4 2024: $534MQ1 2025: $483MQ2 2025: $552MQ3 2025: $593MQ4 2025: $637MQ1 2026: $567MQ2 2026: $679MQ3 2026: $715M
Q4 2023: $469MQ1 2024: $465MQ2 2024: $501MQ3 2024: $484MQ4 2024: $534MQ1 2025: $483MQ2 2025: $552MQ3 2025: $593MQ4 2025: $637MQ1 2026: $567MQ2 2026: $679MQ3 2026: $715M
QuarterRevenueYoY
Q3 2026$714.5M+21%
Q2 2026$679M+23%
Q1 2026$566.8M+17%
Q4 2025$637.3M+19%
Q3 2025$592.8M+23%
Q2 2025$552.4M+10%
Q1 2025$482.6M+3.7%
Q4 2024$533.7M+14%

SPXC's revenue has grown year over year for 18 quarters in a row: $715M last quarter, up 21% from the same quarter a year ago.

RKLB Free Cash Flow

Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
QuarterFree cash flowYoY
Q3 2026-$23.9M+$45.5M
Q2 2026-$110.1M-$54.8M
Q1 2026-$77.4M+$5.5M
Q4 2025-$114.2M-$90.2M
Q3 2025-$69.4M-$27.5M
Q2 2025-$55.3M-$26.9M
Q1 2025-$82.9M-$61.1M
Q4 2024-$23.9M+$28.7M

RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.

SPXC Free Cash Flow

Q4 2023: $119MQ1 2024: $600,000Q2 2024: $47MQ3 2024: $44MQ4 2024: $157MQ1 2025: −$16MQ2 2025: $35MQ3 2025: $96MQ4 2025: $127MQ1 2026: $12MQ2 2026: $69MQ3 2026: $19M
Q4 2023: $119MQ1 2024: $600,000Q2 2024: $47MQ3 2024: $44MQ4 2024: $157MQ1 2025: −$16MQ2 2025: $35MQ3 2025: $96MQ4 2025: $127MQ1 2026: $12MQ2 2026: $69MQ3 2026: $19M
QuarterFree cash flowYoY
Q3 2026$19.3M-80%
Q2 2026$68.5M+97%
Q1 2026$12.1M+$28.5M
Q4 2025$126.7M-19%
Q3 2025$96.1M+121%
Q2 2025$34.8M-26%
Q1 2025-$16.4M-2833%
Q4 2024$156.7M+32%

SPXC has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.

RKLB Total Shares

Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
PeriodChange %Net change
Quarterly+3.6%+22.6M shares
1 year+23%+124M shares
3 years+35%+168M shares
5 years+46%+204M shares

RKLB has 652M diluted shares, up 23% from a year ago.

SPXC Total Shares

Q4 2023: 47MQ1 2024: 47MQ2 2024: 47MQ3 2024: 47MQ4 2024: 47MQ1 2025: 47MQ2 2025: 47MQ3 2025: 49MQ4 2025: 49MQ1 2026: 51MQ2 2026: 51MQ3 2026: 51M
Q4 2023: 47MQ1 2024: 47MQ2 2024: 47MQ3 2024: 47MQ4 2024: 47MQ1 2025: 47MQ2 2025: 47MQ3 2025: 49MQ4 2025: 49MQ1 2026: 51MQ2 2026: 51MQ3 2026: 51M
PeriodChange %Net change
Quarterly-0.1%-30K shares
1 year+3.5%+1.7M shares
3 years+8.3%+3.9M shares
5 years+8.6%+4M shares
Available history+13%+5.7M shares

SPXC has the edge over RKLB on shareholder dilution, with a more favorable share count trend.

RKLB Net Leverage

RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

SPXC Net Leverage

Q4 2023: 1.6xQ1 2024: 2.4xQ2 2024: 1.9xQ3 2024: 1.7xQ4 2024: 1.1xQ1 2025: 1.9xQ2 2025: 2.1xQ3 2025: 0.6xQ4 2025: 0.3xQ1 2026: 1.0xQ2 2026: 0.8xQ3 2026: 2.2x
Q4 2023: 1.6xQ1 2024: 2.4xQ2 2024: 1.9xQ3 2024: 1.7xQ4 2024: 1.1xQ1 2025: 1.9xQ2 2025: 2.1xQ3 2025: 0.6xQ4 2025: 0.3xQ1 2026: 1.0xQ2 2026: 0.8xQ3 2026: 2.2x
QuarterNet LeverageStatus
Q3 20262.2xModerate
Q2 20260.8xVery low
Q1 20261.0xHealthy
Q4 20250.3xVery low
Q3 20250.6xVery low
Q2 20252.1xModerate
Q1 20251.9xHealthy
Q4 20241.1xHealthy

SPXC's net debt is about 2.2 years of its operating earnings (EBITDA), up from less than a year a year ago.

RKLB Weekly Momentum

MetricValueStatus
RSI46.8Neutral
Stochastic27.6Neutral

RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).

SPXC Weekly Momentum

MetricValueStatus
RSI29.0Oversold
Stochastic11.4Oversold

SPXC's weekly RSI is 29 (oversold) and its Stochastic is 11 (oversold).

RKLB PE vs Industrials Sector

RKLB has no meaningful PE right now: it lost money over the past year.

SPXC PE vs Industrials Sector

MetricSPXCSector medianRelative
PE25x24x5.7% above
PE %335825 pts below

SPXC is trading at 25x earnings, in line with the Industrials sector's median of 24x.

RKLB Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$61.44.3% above
20 week MA$68.15.9% below
50 week MA$77.617% below
100 week MA$56.513% above
200 week MA$31.4104% above

RKLB has the edge over SPXC on trend strength, trading above more of its moving averages.

SPXC Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$161.97% below
20 week MA$190.121% below
50 week MA$204.826% below
100 week MA$185.319% below
200 week MA$147.02.5% above

SPXC has fallen below most of its moving averages, though it's still 2.5% above its 200-week average.

RKLB Yearly ROI

YearStart priceEnd priceROI
2020$9.82$10.3+4.9%
2021$10.3$12.0+17%
2022$12.0$3.77-69%
2023$3.77$5.53+47%
2024$5.53$27.2+392%
2025$27.2$70.7+160%
2026 YTD$70.7$64.1-9.3%

RKLB has the edge over SPXC on returns for 2026, with the stronger performance.

SPXC Yearly ROI

YearStart priceEnd priceROI
2020$50.6$53.9+6.5%
2021$53.9$57.9+7.3%
2022$57.9$65.3+13%
2023$65.3$101.0+55%
2024$101.0$146.0+45%
2025$146.0$208.5+43%
2026 YTD$208.5$150.6-28%

SPXC has finished every year since 2020 higher, and it's down 28% so far in 2026.

Give your agent the market.

Get API key